Takeaways
- Oncology growth requires coordination across marketing, operations, and physician relations so that increased demand translates into patients receiving care.
- Tracking the full path from initial inquiry to completed appointment helps uncover missed follow-ups, scheduling delays, and no-shows that undermine marketing results.
- Every cancer type represents a distinct market, so growth strategies must account for local incidence, patient populations, competitors, clinical expertise, and available capacity.
- Screening outreach should encourage people to take action through helpful, sensitive messaging that avoids fear or implying knowledge of an individual’s cancer risk.
- Combining consumer marketing with strong referring-provider relationships builds patient trust while reducing dependence on referral sources that can change after mergers or acquisitions.
- Physician liaison outreach becomes more effective when teams prioritize relevant referral opportunities, understand referral behavior, and address barriers to sending patients.
- Building trust before diagnosis requires content across the patient journey, including signs and symptoms, screening, testing, treatment options, and patient stories.
- Marketing investments should focus on cancer types where the organization has a realistic opportunity to grow, guided by market demand, treatment patterns, organizational priorities, and capacity.
